Autor: |
Holger Kubas, Ilya Pyatkin, Maksims Vanejevs, Ulrich Abel, Udo Meyer, Mirko Hechenberger, Valerjans Kauss, Raisa Ambartsumova, Alexey I. Polosukhin, Bjoern Krueger, Ronalds Zemribo |
Rok vydání: |
2013 |
Předmět: |
|
Zdroj: |
Bioorganicmedicinal chemistry letters. 23(16) |
ISSN: |
1464-3405 |
Popis: |
A virtual screening approach using various in silico methodologies led to the discovery of 2-(m-tolylamino)-7,8-dihydroquinazolin-5(6H)-one (1) as a moderately active negative allosteric modulator (NAM) of the metabotropic glutamate receptor subtype 5 (mGluR5) showing high selectivity against the subtype mGluR1. Modifications of the parent compound by rational design yielded a series of highly potent derivatives which will serve as valuable starting points for further hit-to-lead optimization efforts toward a suitable drug candidate for the treatment of L-DOPA induced dyskinesia. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|